Insulin and sulfonylurea therapy in NIDDM patients: Are the effects on lipoprotein metabolism different even with similar blood glucose control?

Diabetes

Volumn 46, Issue 10, 1997, Pages 1601-1606

  Romano, Geremia ^a   Patti, Lidia ^a   Innelli, Francesca ^a   Di Marino, Lucrezia ^a   Annuzzi, Giovanni ^a   Iavicoli, Mario ^b   Coronel, Gustavo A ^b   Riccardi, Gabriele ^a   Rivellese, Angela A ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; SULFONYLUREA; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT SYSTEM; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030812762     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.46.10.1601     Document Type: Article

References (33)

1. Pyörälä K, Laakso M, Uusitupa M: Diabetes and atherosclerosis: an epidemiological view. Diabetes Metab Rev 3:463-524, 1987
2. Bierman EL: Atherogenesis in diabetes. Arterioscler Thromb 12:647-656, 1992
3. Laakso M: Epidemiology of diabetic dyslipidemia Diabetes Rev 3:408-422, 1995
4. Kennedy L, Walshe K, Hadden DR, Weaver JA, Buchanan KD: The effect of intensive dietary therapy on serum high density lipoprotein cholesterol in patients with type II (non insulin dependent) diabetes mellitus: a prospective study. Diabetologia 23:24-27, 1982
5. Taskinen MR, Beltz WF, Harper I, Fields RM, Schonfeld G, Grundy SM, Howard BV: Effects of NIDDM on very low density lipoprotein triglyceride and apolipoprotein B metabolism: studies before and after sulfonylurea therapy. Diabetes 35:1268-1277, 1986
6. Wu MS, Johnston P, Shen WH, Hollenbeck CB, Yang CY, Goldfine ID, Chen YD, Reaven GM: Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients. Diabetes Care 13:1-8, 1990
7. Taskinen MR, Kuusi T, Helve E, Nikkilä EA, Yki-Järvinen H: Insulin therapy induces antiatherogenic changes of serum lipoproteins in non insulin-dependent diabetes. Arteriosclerosis 8:168-177, 1988
8. Taskinen MR, Packard CJ, Shepherd J: Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM. Diabetes 39:1017-1027, 1990
9. Nathan DM, Roussel A, Godine JE: Glyburide or insulin for metabolic control in non-insulin-dependent diabetes mellitus: a randomized, double-blind study. Ann Intern Med 108:334-340, 1988
10. Colwell JA: DCCT findings: applicability and implications for NIDDM. Diabetes Rev 2:227-340, 1994
11. Ruotolo G, Parlavecchia M, Taskinen MR: Normalization of lipoprotein composition by intraperitoneal insulin in NIDDM. Diabetes Care 17:6-12, 1994
12. Knudsen P, Eriksson J, Lahdenperä S, Kahri J, Groop L, Taskinen MR, the Botnia Study Group: Changes of lipolytic enzymes cluster with insulin resistance syndrome. Diabetologia 38:344-350, 1995
13. World Health Organization: WHO Expert Committee on Diabetes Mellitus. Second Report. Geneva, World Health Org., 1980 (Tech. Rep. Ser., no. 646)
14. Diabetes and Nutrition Study Group of the EASD: Recommendations for the nutritional management of patients with diabetes mellitus. Diabetes Nutr Metab 8:1-11, 1995
15. Hatch FT, Lees RS: Practical methods for plasma lipoprotein analysis. In Advances in Lipid Research. Vol 6. Paoletti R, Kritchevsky D, Eds. London, Academic Press, 1968, p. 1-86
16. Lopes-Virella MF, Stone P, Ellis S, Colwell JA: Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 23:882-884, 1977
17. 3, without contamination of Lp(a) in human plasma. Clin Chim Acta 113:123-134, 1981
18. Patti L, Romano G, Di Marino L, Annuzzi G, Mancini M, Riccardi G, Rivellese AA: Abormal distribution of VLDL subfractions in type 1 (insulin-dependent) diabetic patients: could plasma lipase activities play a role? Diabetologia 36:155-160, 1993
19. Redgrave TR, Carlson LA: Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo- and hypertriglyceridemic men. J Lipid Res 20:217-229, 1979
20. Nilsson-Ehle P, Ekman R: Rapid, simple and specific assay for lipoprotein lipase and hepatic lipase. Artery 3:194-209, 1977
21. Grafnetter D: World Health Organization (WHO) coordinated quality control in the lipid laboratory. Giorn Arterioscl 2:113-128, 1977
22. 1c. Diabetes 27:102-107, 1978
23. Gennaro WD, Van Norman JD: Quantitation of free, total, and antibody-bound insulin in insulin-treated diabetics. Clin Chem 27:873-879, 1975
24. Snedecor GW, Cochran WG: Statistical Methods. 7th ed. Ames, IA, The Iowa State University Press, 1980
25. Patti L, Di Marino L, Maffettone A, Romano G, Annuzzi G, Riccardi, Rivellese AA: Very low density subfraction abnormalities in IDDM patients: any effect of blood glucose control? Diabetologia 38:1419-1424, 1995
26. Mack WJ, Krauss RM, Hodio HN: Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS) Arterioscler Thromb Vasc Biol 16:697-704, 1996
27. Malmstrom R, Watson T, Rannikko S, Packard C, Shepherd J, Taskinen MR: Metabolic basis of hypertriglyceridemic effects of insulin in normal men (Abstract). Diabetes 44 (Suppl. 1):43A, 1995
28. Nicoll A, Lewis B: Evaluation of the roles of lipoprotein lipase and hepatic lipase in lipoprotein metabolism: in vivo and in vitro studies in man. Eur J Clin Invest 10:487-495, 1980
29. Krapp A, Ahle S, KerstingS, Hua Y, Kneser K, Nielsen M, Gliemann J, Beisiegel U: Hepatic lipase mediates the uptake of chylomicrons and β-VLDL into cells via the LDL receptor-related proteins (LRP). J Lipid Res 37:926-936, 1996
30. Hollenbeck CB, Chen Y-DI, Greenfield MS, Lardinois CK, Reaven GM: Reduced plasma high density lipoprotein-cholesterol concentrations need not increase when hyperglycemia is controlled with insulin in non insulin dependent diabetes mellitus. J Clin Endocrin Metab 62:605-608, 1986
31. Howard BV: Lipoprotein metabolism in diabetes mellitus. J Lipid Res 28:613-628, 1987
32. Taskinen MR, Kuusi T: Enzymes involved in triglyceride hydrolysis. Baillieres Clin Endocrinol Metab 1:639-666, 1987
33. 2 subfractions with hepatic lipase. J Lipid Res 33:1269-1279, 1992